GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » Operating Margin %

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Operating Margin % : 12.68% (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Gulf Pharmaceutical Industries PSC Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Gulf Pharmaceutical Industries PSC's Operating Income for the three months ended in Dec. 2023 was د.إ52 Mil. Gulf Pharmaceutical Industries PSC's Revenue for the three months ended in Dec. 2023 was د.إ413 Mil. Therefore, Gulf Pharmaceutical Industries PSC's Operating Margin % for the quarter that ended in Dec. 2023 was 12.68%.

Good Sign:

Gulf Pharmaceutical Industries PSC operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Gulf Pharmaceutical Industries PSC's Operating Margin % or its related term are showing as below:

ADX:JULPHAR' s Operating Margin % Range Over the Past 10 Years
Min: -154   Med: -2.31   Max: 15.57
Current: -2.66


ADX:JULPHAR's Operating Margin % is ranked worse than
68.24% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 6.385 vs ADX:JULPHAR: -2.66

Gulf Pharmaceutical Industries PSC's 5-Year Average Operating Margin % Growth Rate was 55.10% per year.

Gulf Pharmaceutical Industries PSC's Operating Income for the three months ended in Dec. 2023 was د.إ52 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was د.إ-44 Mil.

Warning Sign:

Gulf Pharmaceutical Industries PSC had lost money in 83% of the time over the past 12quarters.


Gulf Pharmaceutical Industries PSC Operating Margin % Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gulf Pharmaceutical Industries PSC Operating Margin % Chart

Gulf Pharmaceutical Industries PSC Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -154.00 -36.21 -5.37 -1.96 -2.66

Gulf Pharmaceutical Industries PSC Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.05 -1.43 -11.87 -11.26 12.68

Competitive Comparison of Gulf Pharmaceutical Industries PSC's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Gulf Pharmaceutical Industries PSC's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gulf Pharmaceutical Industries PSC's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Gulf Pharmaceutical Industries PSC's Operating Margin % falls into.



Gulf Pharmaceutical Industries PSC Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Gulf Pharmaceutical Industries PSC's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-43.5 / 1638
=-2.66 %

Gulf Pharmaceutical Industries PSC's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=52.3 / 412.6
=12.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gulf Pharmaceutical Industries PSC  (ADX:JULPHAR) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Gulf Pharmaceutical Industries PSC Operating Margin % Related Terms

Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Business Description

Traded in Other Exchanges
N/A
Address
Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE
Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Headlines

No Headlines